An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer
Clinical trial NCT00215683 · COMPLETED
Trial details
- NCT number
- NCT00215683
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.